All patients who have had a heart attack are typically treated using beta blockers. According to a Swedish study conducted ...

As cardiovascular disease progresses, the issue of switching from one β blocker to another is an important consideration as to how to optimize the effectiveness of adrenergic blockade.

The dose of the first- or second-generation β blocker that the patient is receiving is an important consideration for the switching regimen chosen. The major factors to be kept in mind when ...

A 240-year-old drug called digoxin could save the National Health Service (NHS) at least £100 million each year when treating ...

Blockages in coronary arteries cause sudden heart attacks, leading to heart muscle damage. In contrast, heart failure is a ...

A study from the University of Birmingham has indicated that digoxin could be used to treat senior individuals with heart ...

Using a most cost-effective drug to treat some of the most common and dangerous heart conditions could save the NHS a ...

The following is a summary of “Cost-effectiveness of digoxin versus beta blockers in permanent atrial fibrillation: the Rate Control Therapy Evaluation in Permanent Atrial Fibrillation (RATE-AF) ...

A 240-year-old drug called digoxin could save the National Health Service (NHS) at least £100 million each year when treating older patients with atrial fibrillation and heart failure.

First used in 1785, this century-old medication is now emerging as a modern solution with significant healthcare benefits ...